Striking the right balance between innovation and drug price competition: putting the Hatch-Waxman Act into perspective

Food Drug Law J. 1999;54(2):185-6.
No abstract available

MeSH terms

  • Congresses as Topic
  • Drug Costs
  • Drug Industry / economics
  • Drug Industry / legislation & jurisprudence*
  • Economic Competition*
  • Humans
  • Patents as Topic / legislation & jurisprudence
  • United States